Head and Neck Squamous Cell Carcinoma (HNSCC) Not Yet Recruiting Phase 4 Trials for DB00293 (Raltitrexed)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs